Ceevit - 250mg

Tablet

Pack Size : 10 Tablet x 1 Strip

Generics : Vitamin C (Ascorbic acid)

Manufacturer : Square Pharmaceuticals Ltd.

Best Price * TK 19.00

* Delivery will be done in Dhaka city only.

Alternative Product

Tablet Ascobex - 250mg Beximco Pharmaceuticals Ltd.

Tk 1.89

Tablet Ceegram - 10 tablets Incepta Pharmaceuticals Ltd.

Tk 100.00

Tablet Ceevit Forte Orange - 1gm Square Pharmaceuticals Ltd.

Tk 103.40

Syrup HI-C - 1gm Eskayef Pharmaceuticals Ltd.

Tk 33.32

Tablet Nutrivit C 250 mg Tab ACI Limited

Tk 2.00

More Information About - Ceevit - 250mg

Description

Generic Name

Vitamin C (Ascorbic Acid)

Precaution

Should be given with caution to patient with hyperoxaluria.

Indication

Treatment or prevention of, Vitamin C Deficiency, Scurvy, Infection, Trauma, Burns, Cold exposure, Following Surgery, common cold, Fever, scurvy, Stress, Cancer, Methaemoglobinaemia and Children receiving unfortified formulas. Also indicated in, Hematuria, Dental Caries, Gum Diseases, Pyorrhea, Acne, Infertility, Atherosclerosis, Fractures, Leg ulcers, Hay fever, Vascular thrombosis prevention, Levodopa toxicity, Arsenic toxicity.

Contra Indication

N/A

Dose

N/A

Side Effect

Flushing, Flank pain, Faintness, headache, Diarrhea, dyspepsia, nausea, vomiting, Hyperoxaluria (large doses)

Pregnancy Category

Name : A

Description

Adequate and well-controlled human studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).

Mode of Action

Vitamin C: Necessary for collagen formation and tissue repair; plays a role in oxidation/reduction reactions as well as other metabolic pathways including synthesis of catecholamines, carnitine, and steroids; also plays a role in conversion of folic acid to folinic acid.

Interaction

Vit C: Deferroxamine, hormonal contraceptives, flufenazine, warfarin, elemental iron, salicylates, warfarin, fluphenazine, disulfiram, mexiletine, vitamin B12.

Pregnancy Category Note

Pregnancy No adverse developmental outcomes are reported in the published literature There are no available data on use of Ascor in pregnant women to inform a drug-associated risk of adverse developmental outcomes Lactation There are no data on the presence of ascorbic acid in human milk following IV dosing in lactating women Ascorbic acid is present in human milk after maternal oral intake

Adult Dose

Oral Scurvy Adult: Prevention: 25-75 mg daily. 4 tablets 2 to 3 times daily. Treatment: >250 mg daily, given in divided doses. May also be given via IM/IV/SC admin. 250-500mg IV qDay/BID for at least 2 weeks. Thalassaemia Adult: 100-200 mg daily, to be given with desferrioxamine. Common cold: 1 gm or more daily in divided doses, i.e. 4 tablets daily. In wound healing: 2-4 tablets 2 to 3 times daily In other conditions: 1-2 tablets daily For the reduction of risk of stroke in the elderly: 1-2 tablets daily. 1 effervescent tablet daily with a meal or as directed by physician. Dissolve one tablet in half glass (100 ml) of water and drink instantly.

Child Dose

Children: Child: 1 mth-4 yr: 125-250 mg daily; 4-12 yr: 250-500 mg daily; 12-18 yr: 500 mg-1 g daily. Doses to be given in 1-2 divided doses. Thalassaemia Child: 100-200 mg daily, to be given with desferrioxamine. Metabolic disorders Child: Neonate: 50-200 mg daily, adjust if needed; 1 mth-18 yr: 200-400 mg daily in 1-2 divided doses, up to 1 g daily may be needed.

Renal Dose

N/A

Administration

May be taken with or without food. IV Preparation Dilute with large volume of compatible fluid to minimize adverse reactions Compatible w/ most common diluents (dextrose solns, NS, LR, Ringer's, ?NS, dextrose-saline, dextrose-LR etc) IV Administration Avoid rapid infusion

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.